Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Stock-Based Compensation (Tables)

v3.23.1
Stock-Based Compensation (Tables)
12 Months Ended
Mar. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock-Based Compensation Expense
Total stock-based compensation expense consists of the following:
 
Years Ended 31 March
(Millions of US dollars) 2023 2022 2021
Liability Awards $ 2.7  $ 3.2  $ 21.7 
Equity Awards 15.7  9.0  18.0 
Total stock-based compensation expense $ 18.4  $ 12.2  $ 39.7 
Summary of Stock Options Available for Grant
The following table summarizes the Company’s shares available for grant as options, RSUs or other equity instruments under the LTIP and 2001 Plan:
 
Shares
Available for
Grant
Balance at 31 March 2021
22,087,623 
Granted (597,927)
Balance at 31 March 2022
21,489,696 
Granted (2,540,893)
Balance at 31 March 2023
18,948,803 
Schedule of Stock Options Roll Forward The following table summarizes the Company's stock options activity during the noted period:
Outstanding Options
Number of Options Weighted Average
Exercise Price (A$)
Balance at 31 March 2022
—  — 
Granted 269,221  33.05 
Balance at 31 March 2023
269,221  33.05 
Options exercisable at 31 March 2023
—  — 
Restricted Stock Unit Activity
The following table summarizes the Company’s RSU activity:
(Units) Service
Vesting
(2001 Plan)
Performance
Vesting
(LTIP)
Market
Conditions (LTIP)
Total Weighted
Average Fair
Value at Grant
Date (A$)
Outstanding at 31 March 2021
593,486  726,288  1,286,922  2,606,696  19.01 
Granted 233,443  141,015  223,469  597,927  41.73 
Vested (313,641) (248,202) (565,878) (1,127,721) 14.96 
Forfeited (98,613) (327,397) (450,480) (876,490) 27.73 
Outstanding at 31 March 2022
414,675  291,704  494,033  1,200,412  27.83 
Granted 1,279,127  268,009  724,536  2,271,672  26.12 
Vested (449,458) (87,307) (256,787) (793,552) 25.17 
Forfeited (107,818) (100,377) (91,738) (299,933) 28.46 
Outstanding at 31 March 2023
1,136,526  372,029  870,044  2,378,599  26.97 
Assumptions Used for Restricted Stock Grants
The following table includes the assumptions used for RSU grants (market condition) valued:
Vesting Condition: Market Market Market Market Market Market Market Market
  FY23 FY23 FY23 FY23 FY23 FY23 FY22 FY22
Date of grant 31-Aug-22 31-Aug-22 3-Nov-22 3-Nov-22 3-Nov-22 13-Mar-23 27-Aug-21 9-Sep-21
Dividend yield (per annum) 1.5  % 1.5  % —  % —  % —  % —  % 2.0  % 2.0  %
Expected volatility 41.9  % 33.4  % 42.5  % 35.1  % 43.8  % 36.3  % 40.0  % 40.2  %
Risk free interest rate 3.5  % 3.5  % 4.7  % 4.7  % 4.7  % 4.0  % 0.4  % 0.4  %
Expected life in years 3.0 2.0 0.8 1.8 2.8 2.4 3.0 2.9
JHX stock price at grant date (A$) 33.51 33.51 33.05 33.05 33.05 30.98 52.66 52.12
Number of restricted stock units 387,360 102,250 38,387 39,450 115,688 41,401 130,513 92,956
Schedule Of Fair Value Of Restricted Stock Units Vested
The following table presents the total fair value of all of our restricted stock units vested:
Years ended 31 March
(Millions of US dollars) 2023 2022 2021
Total fair value vested $ 18.4  $ 42.6  $ 27.8 
Cash Settled Units Activity
The following represents the activity related to the CSUs:
FY23 FY22
Granted 751,569  423,051 
Vested 237,600  433,872 
Cancelled 325,459  1,292,934